By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today reported first-quarter revenue growth of one percent, as it cut its net loss sharply on lower costs.

The Hopkinton, Mass.-based firm reported total revenues of $28.7 million for the three-month period ended March 31, compared to $28.5 million for the first quarter of 2009. Though its revenues were up only one percent, excluding the effect of divested non-core operations over the past year, Caliper's revenues were up 13 percent year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.